A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
NCT ID: NCT01519934
Last Updated: 2017-12-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2011-10-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifting and Tightening of the Face and Neck Following an Increased Density Treatment
NCT01519206
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
NCT01713985
Evaluation of the Ulthera® System for Treatment of the Face and Neck
NCT01713907
Treatment of the Face and Neck With Lower Ulthera System Energy Settings
NCT01713998
Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck
NCT01708512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ulthera-treated subjects
All enrolled subjects will have received an Ulthera treatment prior to enrollment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject in good health.
* Received Ultherapy™ treatment prior to or on October 1, 2011, and must have had pre-treatment baseline photographs taken.
* Willingness and ability to comply with protocol requirements, including returning for follow-up visits.
* Absence of physical or psychological conditions unacceptable to the investigator.
Exclusion Criteria
* Significant scarring in areas treated.
* Open wounds or lesions in the areas treated.
* Severe or cystic acne on the areas treated.
* Inability to understand the protocol or to give informed consent.
25 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ulthera, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitchel Goldman, MD
Role: PRINCIPAL_INVESTIGATOR
Dermatology Cosmetic Laser Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology Cosmetic Laser Associates
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ULT-120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.